不良研究所

Molecular Modeling and New Drug Development: Development of Biological and Chemical Agents

Researchers involved with this research team are looking at different chemical and biological approaches to the discovery and development of cancer therapies. Chemical agents refer to synthetic molecules, small peptides or natural products, whereas biological therapies use the patient鈥檚 immune system, either directly or indirectly, to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Experts in cancer biology, cancer pharmacology, organic chemistry, molecular modeling and radiobiology exploit the genomic and proteomic technologies as well as the best bioinformatics tools with the overarching goal to develop 鈥渟mart鈥 drugs against key targets for therapeutic intervention.

Theme Leader:Dr. Jian Hui Wu, Lady Davis Institute for Medical Research, 不良研究所

Members:

Dr. Moulay Alaoui-Jamali, Lady Davis Institute for Medical Research, 不良研究所

Dr. Raquel Aloyz, Lady Davis Institute for Medical Research, 不良研究所

Dr. Richard B茅liveau, Universit茅 du Quebec a Montr茅al

Dr. Katherine Borden, Universit茅 de Montr茅al

Dr. Marc Fabian, Lady Davis Institute for Medical Research, 不良研究所

Dr. Sylvie Mader, Universit茅 de Montr茅al

Dr. Koren Mann, Lady Davis Institute for Medical Research, 不良研究所

Dr. Thierry Muanza, Lady Davis Institute for Medical Research, 不良研究所

Dr. Lawrence Panasci, Lady Davis Institute for Medical Research, 不良研究所

Dr. Michael Pollak, Lady Davis Institute for Medical Research, 不良研究所

Dr. Stephane Richard, Lady Davis Institute for Medical Research, 不良研究所

Dr. Siham Sabri, Research Institute 不良研究所 Health Centre

Dr. Uri Saragovi, Lady Davis Institute for Medical Research, 不良研究所

Dr. Ivan Topisirovic, Lady Davis Institute for Medical Research, 不良研究所

Dr. Mark Trifiro, Lady Davis Institute for Medical Research, 不良研究所

Dr. Josie Ursini-Siegel, Lady Davis Institute for Medical Research, 不良研究所

Dr. John White, Lady Davis Institute for Medical Research, 不良研究所

Dr. Michael Witcher, Lady Davis Institute for Medical Research, 不良研究所

Back to top